Currently, NeuroOne Medical Technologies Corp’s (NMTC) stock is trading at $1.30, marking a gain of 2.27% from last night’s close. At this price, the stock is -36.95% below its 52-week high of $2.06 and 52.80% above its 52-week low of $0.85. Based on the past 30-day period, the stock price is -13.99% below the high and +27.73% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, NMTC’s SMA-200 is $1.1978.
As well, it is important to consider NMTC stock ratios such as price-to-sales, which is currently 11.94.NMTC’s price to book ratio for the most recent quarter was 7.30, resulting in an 12.57 price to cash per share for the period.
How does NeuroOne Medical Technologies Corp (NMTC) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 1 brokerage firms that recommend the stock as a Hold. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 3.00 in simple terms.
NeuroOne Medical Technologies Corp (NMTC): Earnings History
If we examine NeuroOne Medical Technologies Corp’s recent earnings history, in the last quarter ended on 12/30/2023, it posted adjusted earnings per share of -$0.14, slashing the consensus of -$0.14. In other words, it beat the consensus by $0, resulting in a 0.00% surprise. In the 3 months period before the previous quarter which was closed on 12/30/2023, the stock recorded adjusted earnings per share of -$0.14 in contrast with the Outlook of -$0.14. That was a difference of $0 and a surprise of 0.00%.
NeuroOne Medical Technologies Corp (NASDAQ: NMTC) Ownership Details
I will give a breakdown of the key shareholders in NeuroOne Medical Technologies Corp (NMTC). Recent figures show that the company’s insiders hold 12.21% of shares. A total of 23 institutional investors hold shares in the company, making 25.94% of its stock and 29.55% of its float.
Dec 30, 2023, it was reported that the Company’s largest institutional holder is Nantahala Capital Management, LLC holding total of 2.43 million shares that make 20.30% of the company’s total number of shares and are currently priced at 3.13 million.
The securities firm AWM Investment Company, Inc. holds 1.45 million shares of NMTC, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 12.12%, and the holding percentage of shares is valued at 1.87 million.
An overview of NeuroOne Medical Technologies Corp’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests NeuroOne Medical Technologies Corp (NMTC) traded 253,322 shares per day, with a moving average of $1.1778 and price change of +0.1401. With the moving average of $1.2227 and a price change of -0.0899, about 169,459 shares changed hands on average over the past 50 days. Finally, NMTC’s 100-day average volume is 200,786 shares, alongside a moving average of $1.3152 and a price change of +0.3902.
